Management of Acute Upper Gastrointestinal Bleeding in Chronic Liver Disease (EASL)

Initial Resuscitation

• Secure the airway promptly in patients with massive hemorrhage or hepatic encephalopathy, with endotracheal intubation when needed – strong recommendation. 1
• Restore circulatory volume using crystalloids (or colloids if required) to achieve hemodynamic stability – strong recommendation. 1
• Place two large‑bore intravenous cannulae in the antecubital fossae for patients who are hemodynamically compromised – strong recommendation. 2
• Adopt a restrictive transfusion strategy: transfuse red blood cells only when hemoglobin < 7 g/dL and maintain a target of 7–9 g/dL – strong recommendation. 1, 3
• Avoid liberal transfusion because blood product administration raises portal pressure and worsens bleeding outcomes – strong recommendation. 3

Immediate Pharmacological Therapy (Pre‑Endoscopy)

• Start vasoactive drug therapy as soon as variceal bleeding is suspected, without waiting for endoscopic confirmation – strong recommendation. 1, 3

  • Terlipressin: 2 mg IV every 4 h for the first 48 h, then 1 mg IV every 4 h.
  • Somatostatin: 250 µg IV bolus, then continuous infusion 250 µg/h (can be increased to 500 µg/h).
  • Octreotide: 50 µg IV bolus, then continuous infusion 50 µg/h.

• Continue vasoactive therapy for 3–5 days after endoscopic confirmation to prevent early re‑bleeding – strong recommendation. 1

• Provide antibiotic prophylaxis with ceftriaxone 1 g IV daily (first‑line for decompensated cirrhosis or quinolone‑resistant settings); use norfloxacin only if ceftriaxone unavailable and resistance is low – strong recommendation. 1
• Maintain antibiotic prophylaxis for up to 7 days; this reduces infection rates (> 50 % of patients), improves bleeding control, and enhances survival – strong recommendation. 1

Endoscopic Management

• Perform upper endoscopy within 12 hours of admission once the patient is hemodynamically stable – strong recommendation. 1
• Administer erythromycin 250 mg IV 30–120 min before endoscopy to improve gastric emptying and visibility, unless contraindicated (e.g., QT prolongation) – strong recommendation. 1

Esophageal Varices

• Endoscopic band ligation (EBL) is the treatment of choice; it is more effective than sclerotherapy, has fewer adverse effects, and may improve survival – strong recommendation. 1
• Sclerotherapy may be used only when EBL is technically infeasible – conditional recommendation. 1

Gastric (Cardiofundal) Varices

• Cyanoacrylate injection or EBL are both acceptable therapeutic options – strong recommendation. 1

• EBL should be limited to small gastric varices that can be fully suctioned into the ligation device – conditional recommendation. 1

• Recognize that up to 30 % of cirrhotic patients bleed from non‑variceal sources; therefore, endoscopy is essential for accurate diagnosis – strong recommendation. 1

Rescue Therapy for Treatment Failure

• Transjugular intra‑hepatic portosystemic shunt (TIPS) is the preferred rescue therapy for persistent bleeding or early re‑bleeding despite optimal endoscopic and pharmacologic treatment – strong recommendation. 1
• Balloon tamponade may be employed as a temporary bridge while awaiting definitive therapy – conditional recommendation. 1

Monitoring and Prevention of Complications

• Bacterial infections occur in > 50 % of patients and can precipitate re‑bleeding; vigilant monitoring and prophylaxis are mandatory – strong recommendation. 1

• Watch for hepatic encephalopathy (manage with lactulose or lactitol), renal function deterioration (avoid nephrotoxic agents and maintain fluid balance), aspiration pneumonia, and spontaneous bacterial peritonitis – strong recommendation. 1

• Discontinue beta‑blockers, diuretics, and other hypotensive medications during the acute bleeding episode – strong recommendation. 1
• Avoid nephrotoxic drugs (NSAIDs, aminoglycosides) and large‑volume paracentesis while bleeding is active – strong recommendation. 1

Common Pitfalls to Avoid

• Delaying vasoactive therapy until after endoscopy – strong recommendation to start immediately. 1
• Liberal transfusion strategies – increase portal pressure and worsen outcomes; adhere to restrictive thresholds. 3
• Omitting antibiotic prophylaxis – infections independently predict failure to control bleeding and mortality. 1
• Performing endoscopy before achieving hemodynamic stabilization – ensure resuscitation first. 1, 2
• Continuing beta‑blockers during acute bleeding – should be held. 1
• Using tranexamic acid – provides no benefit in variceal bleeding and may raise venous thrombo‑embolic risk. 3
• Routine administration of fresh‑frozen plasma, platelets, or recombinant factor VIIa – not recommended; they do not improve outcomes and may exacerbate portal hypertension. 3

Emergency Department Management of Acute Variceal Bleeding in Cirrhosis

Immediate Resuscitation

• Secure two large‑bore intravenous lines and begin crystalloid infusion, aiming for a mean arterial pressure > 65 mmHg while avoiding aggressive over‑resuscitation. 4
• Adopt a restrictive transfusion strategy: transfuse packed red blood cells only when hemoglobin falls below 7 g/dL and maintain a target range of 7–9 g/dL; raise the threshold to 8–9 g/dL in patients with active cardiovascular disease. 5
• Cross‑match six units of packed red blood cells immediately upon presentation. 6
• Do not give fresh frozen plasma, platelets, or cryoprecipitate routinely; reserve these products for massive hemorrhage with documented coagulopathy (fibrinogen < 120 mg/dL, platelets < 50 × 10⁹/L, markedly elevated INR) because unnecessary transfusion can precipitate portal vein thrombosis and worsen portal hypertension. 7

Airway Management

• Perform endotracheal intubation without delay in any patient with massive ongoing hematemesis, hepatic encephalopathy grade 3‑4, inability to maintain SpO₂ > 90 %, or high risk of aspiration. 8

Pharmacologic Therapy (Pre‑Endoscopy)

• Start a vasoactive agent (octreotide, somatostatin, or terlipressin) immediately when variceal bleeding is suspected, without waiting for endoscopic confirmation. 9
• Continue vasoactive therapy for 3–5 days after endoscopic confirmation to reduce early re‑bleeding. (citation not required because not provided)

Antibiotic Prophylaxis

• Administer prophylactic antibiotics at presentation; this reduces bacterial infections by > 50 %, lowers re‑bleeding rates, and improves survival. [8][7]9
• First‑line regimen: ceftriaxone 1 g IV daily for up to 7 days (preferred in decompensated cirrhosis or settings with quinolone resistance). 9
• If ceftriaxone is unavailable and quinolone resistance is low, use oral norfloxacin 400 mg twice daily or ciprofloxacin 500 mg twice daily for 7 days. [8][9]

Monitoring and Level of Care

• Admit patients to an intensive‑care or high‑dependency unit for continuous hemodynamic monitoring. [8][6]7
• Place central venous access when the patient is hemodynamically unstable or requires vasopressor support. 6

Endoscopic Management

• Perform upper endoscopy within 12 hours of admission once hemodynamic stability is achieved. [6][7]
• Give erythromycin 250 mg IV 30–120 minutes before endoscopy to improve gastric emptying and visualization (check QTc first; avoid if QTc > 500 ms). 7
• For esophageal varices, use endoscopic band ligation (EBL) as first‑line therapy; it is more effective than sclerotherapy, has fewer complications, and may improve survival. 6
• Reserve sclerotherapy only when EBL is technically impossible. 6
• For cardio‑fundal gastric varices, either cyanoacrylate injection or EBL is acceptable; limit EBL to small varices that can be fully suctioned into the device. 7

Rescue Therapy for Treatment Failure

• If bleeding persists or recurs despite optimal endoscopic and pharmacologic therapy, transjugular intrahepatic portosystemic shunt (TIPS) is the preferred rescue intervention. [6][7]
• Balloon tamponade (Sengstaken‑Blakemore or Minnesota tube) may be employed as a temporary bridge (maximum 24 hours) while arranging TIPS or transfer; ensure airway protection before insertion. [6][7]8

Key Pitfalls (Supported by Evidence)

• Delaying vasoactive therapy until after endoscopy increases the risk of ongoing bleeding. 9
• Liberal transfusion (hemoglobin > 7 g/dL) raises portal pressure and mortality; adhere to restrictive thresholds. 7
• Omitting antibiotic prophylaxis leads to higher infection rates, which independently predict bleeding failure and death. [8][7]9
• Continuing beta‑blockers during acute bleeding worsens hypotension and should be held. (no citation provided, omitted)
• Routine reversal of anticoagulation with blood products is unnecessary unless hemorrhage is life‑threatening. (no citation provided, omitted)
• Aspirin for secondary cardiovascular prevention should not be stopped during acute bleeding unless hemostasis cannot be achieved. (no citation provided, omitted)

First‑Hour Management of Acute Variceal Hemorrhage

Immediate Resuscitation (Minutes 0‑15)

• Insert at least two 16‑gauge peripheral intravenous catheters in the ante‑cubital region for rapid fluid and blood product administration in any patient presenting with suspected variceal bleeding【10】.
• Cross‑match six units of packed red blood cells immediately on arrival to enable prompt transfusion if needed【10】.
• Obtain central venous access when the patient is hemodynamically unstable or requires vasopressor support【10】.
• Perform endotracheal intubation without delay in patients with massive ongoing hematemesis, severe hepatic encephalopathy, inability to maintain oxygen saturation > 90 %, or high aspiration risk【10】.
• Adopt a restrictive transfusion strategy: transfuse packed red cells only when hemoglobin falls below 7 g/dL, aiming for a target range of 7‑9 g/dL (raise to 8‑9 g/dL in active cardiovascular disease)【11】.
• Correct coagulation abnormalities (prothrombin time, platelet count) only when clinically indicated, not routinely【10】.

Pharmacologic Therapy (Minutes 15‑30)

• Start vasoactive drug therapy as soon as variceal bleeding is suspected, without waiting for endoscopic confirmation【11】.
  
  • Octreotide regimen: 50 µg IV bolus followed by continuous infusion of 50 µg/h【11】.
  • Terlipressin regimen (alternative): 2 mg IV every 4 h for the first 48 h, then 1 mg IV every 4 h【11】.
• Continue vasoactive therapy for 3‑5 days after endoscopic confirmation to reduce early re‑bleeding【11】.

Antibiotic Prophylaxis (Critical)

• Administer prophylactic antibiotics immediately at presentation; this reduces bacterial infections by > 50 %, lowers re‑bleeding rates, and improves survival【11】.
• First‑line agent: Ceftriaxone 1 g IV once daily (preferred in decompensated cirrhosis or settings with high quinolone resistance)【11】.
• If ceftriaxone unavailable and quinolone resistance is low, use oral norfloxacin 400 mg twice daily or ciprofloxacin 500 mg twice daily【11】.
• Limit antibiotic prophylaxis to a maximum of 7 days, discontinuing when hemorrhage resolves and vasoactive drugs are stopped【11】.

Monitoring & Disposition (Minutes 30‑60)

• Admit the patient to an intensive‑care or high‑dependency unit equipped for continuous hemodynamic monitoring【10】.
• Transfer to a specialized center when local personnel lack expertise in variceal‑bleeding management【10】.
• Schedule an urgent upper endoscopy within 12 hours of admission once hemodynamic stability is achieved【11】【10】.

Endoscopic Management (Within 12 Hours)

• Perform endoscopic variceal band ligation as the first‑line treatment for esophageal varices【11】.
• Reserve endoscopic variceal sclerotherapy for cases where band ligation is not feasible or bleeding persists despite banding【10】.

Rescue Therapy Planning

• If bleeding persists or recurs despite optimal pharmacologic and endoscopic therapy, place a transjugular intrahepatic portosystemic shunt (TIPS) as the preferred rescue intervention【11】.
• Consider early (pre‑emptive) TIPS within 72 hours for high‑risk patients (Child‑Pugh C or Child‑Pugh B with active bleeding on endoscopy)【11】.
• Use balloon tamponade as a temporary bridge (maximum 24 hours) while arranging definitive rescue therapy, ensuring airway protection【11】【10】.

All statements are derived from guideline‑level recommendations (Hepatology 2017; Gut 2000). Evidence strength was not explicitly graded in the source material.